What motivates men age ≥50 years to participate in a screening program for melanoma?

Cancer

Volumn 107, Issue 4, 2006, Pages 815-823

  Janda, Monika ^a,b   Youl, Philippa H ^a   Lowe, John B ^c   Baade, Peter D ^a   Elwood, Mark ^d   Ring, Ian T ^e   Aitken, Joanne F ^a,f  

^a VIERTEL CENTRE FOR RESEARCH IN CANCER CONTROL   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^c UNIVERSITY OF IOWA   (United States)

^d National Cancer Control Initiative   (Australia)

^e UNIVERSITY OF WOLLONGONG   (Australia)

^f UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Early detection; Elderly men; Melanoma; Middle aged men; Screening; Skin cancer

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; ATTITUDE TO HEALTH; AUSTRALIA; BASAL CELL CARCINOMA; CANCER RISK; CANCER SCREENING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; EDUCATION PROGRAM; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; INTERVIEW; KERATINOCYTE CARCINOMA; MAJOR CLINICAL STUDY; MALE; MELANOMA; MOLE RAT; MOTIVATION; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PATIENT PARTICIPATION; PATIENT REFERRAL; PHYSICIAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; TELEPHONE;

ATTITUDE TO HEALTH; CROSS-SECTIONAL STUDIES; EDUCATIONAL STATUS; FEMALE; HEALTH PROMOTION; HUMANS; INTERVIEWS; MALE; MASS SCREENING; MELANOMA; MIDDLE AGED; MOTIVATION; PATIENT PARTICIPATION; PATIENTS; QUEENSLAND; RISK FACTORS; SELF-EXAMINATION; SKIN NEOPLASMS;

EID: 33747155604     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22051     Document Type: Article

References (36)

1. Australian Institute of Health and Welfare (AIHW) and Australasian Association of Cancer Registries (AACR). Cancer in Australia 2001. Canberra, NSW: AIHW; 2004.
2. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10-30.
3. Geller AC, Miller DR, Annas GD, Demierre MF, Gilchrest BA, Koh HK. Melanoma incidence and mortality among US whites, 1969-1999. JAMA. 2002;288:1719-1720.
4. Swetter SM, Geller AC, Kirkwood JM. Melanoma in the older person. Oncology (Williston Park). 2004;18:1187-1196; discussion 96-97.
5. Balch CM, Soong SJ, Atkins MB, et al. An evidence-based staging system for cutaneous melanoma. CA Cancer J Clin. 2004;54:131-149; quiz 82-84.
6. Balch CM, Buzaid AC, Soong SJ, et al. New TNM melanoma staging system: linking biology and natural history to clinical outcomes. Semin Surg Oncol. 2003;21:43-52.
7. Manson JE, Rexrode KM, Garland FC, Garland CF, Weinstock MA. The case for a comprehensive national campaign to prevent melanoma and associated mortality. Epidemiology. 2000;11:728-734.
8. Weinstock MA. Early detection of melanoma. JAMA. 2000;284:886-889.
9. United States Preventive Services Task Force. Screening for skin cancer: recommendations and rationale. Am J Prev Med. 2001;20:44-46.
10. American Cancer Society. Can melanoma be found early? Atlanta: American Cancer Society, 2006. Available at: http://www.cancer.org/docroot/CRI/content/ CRI_2_4_3X_Can_ melanoma_be_found_early_50.asp?sitearea = Accessed February 27, 2006.
11. Burton RC, Howe C, Adamson L, et al. General practitioner screening for melanoma: sensitivity, specificity, and effect of training. J Med Screen. 1998;5:156-161.
12. Girgis A, Clarke P, Burton RC, Sanson-Fisher RW. Screening for melanoma by primary health care physicians: a cost-effectiveness analysis. J Med Screen. 1996;3:47-53.
13. McHenry PM, Hole DJ, MacKie RM. Melanoma in people aged 65 and over in Scotland, 1979-89. BMJ. 1992;304:746-749.
14. Hersey P, Sillar RW, Howe CG, et al. Factors related to the presentation of patients with thick primary melanomas. Med J Aust. 1991;154:583-587.
15. Hanrahan PF, Hersey P D'Este CA. Factors involved in presentation of older people with thick melanoma. Med J Aust. 1998;169:410-414.
16. Bergenmar M, Ringborg U, Mansson Brahme E, Brandberg Y. Nodular histogenetic type - the most significant factor for thick melanoma: implications for prevention. Melanoma Res. 1998;8:403-411.
17. Chamberlain AJ, Fritschi L, Giles GG, Dowling JR Kelly JW. Nodular type and older age as the most significant associations of thick melanoma in Victoria, Australia. Arch Dermatol. 2002;138:609-614.
18. Demierre MF. Thin melanomas and regression, thick melanomas and older men: prognostic implications and perspectives on secondary prevention. Arch Dermatol 2002;138:678-682.
19. English DR, Del Mar C, Burton RC. Factors influencing the number needed to excise: excision rates of pigmented lesions by general practitioners. Med J Aust. 2004;180:16-19.
20. Geller AC, Zhang Z, Sober AJ, et al. The first 15 years of the American Academy of Dermatology skin cancer screening programs: 1985-1999. J Am Acad Dermatol. 2003;48:34-41.
21. Geller AC, Sober AJ, Zhang Z, et al. Strategies for improving melanoma education and screening for men age > or = 50 years: findings from the American Academy of Dermatological National Skin Cancer Screening Program. Cancer. 2002;95:1554-1561.
22. Aitken JF, Elwood JM, Lowe JB, Firman DW, Balanda KP, Ring IT. A randomised trial of population screening for melanoma. J Med Screen. 2002;9:33-37.
23. Lowe JB, Ball J, Lynch BM, et al. Acceptability and feasibility of a community-based screening programme for melanoma in Australia. Health Promot Int. 2004;19:437-444.
24. Aitken JF, Janda M, Lowe JB, et al. Prevalence of whole-body skin self-examination in a population at high risk for skin cancer (Australia). Cancer Causes Control. 2004;15:453-463.
25. Janda M, Elwood M, Ring IT, et al. Prevalence of skin screening by general practitioners in regional Queensland. Med J Aust. 2004;180:10-15.
26. Janda M, Youl PH, Lowe JB, Elwood M, Ring IT, Aitken JF. Attitudes and intentions in relation to skin checks for early signs of skin cancer. Prev Med. 2004;39:11-18.
27. Aitken JF, Youl PH, Janda M, Lowe JB, Ring IT, Elwood M. Increase in skin cancer screening during a community-based randomized intervention trial. Int J Cancer. 2006;118:1010-1016.
28. Youl PH, Janda M, Lowe JB, Aitken JF. Does the type of promotional material influence men's attendance at skin screening clinics? Health Promot J Austr. 2005;16:229-232.
29. Shah BV, Barnwell BG, Bieler GS. SUDAAN user's manual. Cary, NC: Research Triangle Institute; 1996.
30. Youl PH, Janda M, Elwood M, Lowe JB, Ring IT, Aitken JF. Who attends skin cancer clinics within a randomized melanoma screening program? Cancer Detect Prev. 2006;30:44-51.
31. Aitken JF, Janda M, Elwood M, Youl PH, Ring IT, Lowe JB. Clinical outcomes from skin screening clinics within a community-based melanoma screening program. J Am Acad Dermatol. 2006;54:105-114.
32. Weinstock MA, Nguyen FQ, Martin RA. Enhancing skin self-examination with imaging: evaluation of a mole-mapping program. J Cutan Med Surg. 2004;8:1-5.
33. Ford JS, Ostroff JS, Hay JL, et al. Participation in annual skin cancer screening among women seeking routine mammography. Prev Med. 2004;38:704-712.
34. Berwick M, Armstrong BK, Ben-Porat L, et al. Sun exposure and mortality from melanoma. J Natl Cancer Inst. 2005;97:195-199.
35. Murray DM. Design and Analysis of G group-Randomizes Trials. Vol. 27. New York: Oxford University Press; 1998.
36. Helfand M, Mahon SM, Eden KB, Frame PS, Orleans CT. Screening for skin cancer. Am J Prev Med. 2001;20;47-58.